Summary
We have studied the process of mammary cell transformation in vitro using a single cell clone (Clone 18) from a presumptive epithelial cell line, C57MG, derived from a normal mammary gland; a mouse mammary tumor virus (MMTV) host-range variant (RIII)vp4; and the potent initiating carcinogen 7,12-dimethylbenz(a)anthracene (DMBA). After several serial subcultures, cells treated with virus and then with carcinogen exhibited an altered (transformed) morphology, a dramatic increase in anchorage independence, an increase in multinucleation after exposure to cytochalasin B, an enhanced ability to proliferate in low Ca2+ (0.01 mM) medium, and tumorigenicity when inoculated subcutaneously into athymic (nude) mice. Although some of these phenotypic alterations were observed also in cultures treated singly with MMTV or DMBA and in cultures exposed to DMBA before infection with MMTV, enhanced cytochalasin B multinucleation and tumorigenicity were properties observed only in mass cultures of cloned cells first infected with MMTV and then exposed to DMBA. This demonstrates for the first time that exposure of presumptive mammary epithelial cells to MMTV followed by DMBA, but not to either agent alone or to DMBA followed by MMTV, results in malignant transformation of these cells.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bentvelzen, P. Host-virus interactions in murine mammary carcinogenesis. Biochim. Biophys. Acta 355: 236–259; 1974.
DeOme, K. B.; Nandi, S. The mammary-tumor system in mice, a brief review. Burdette, W. J. ed. Viruses inducing cancer. Salt Lake City: University of Utah Press; 1966: 127–137.
Medina, D. Mammary gland as a morphological end point in carcinogenesis studies. J. Toxicol. Environ. Health 1: 551–560; 1976.
Cardiff, R. D.; Wellings, S. R.; Faulkin, L. J. Biology of breast neoplasia. Cancer 39: 2734–2746; 1977.
Weinstein, I. B. Studies on the mechanism of action of tumor promoters and their relevance to mammary carcinogenesis. McGrath, C. M.; Brennan, M.; Rich, M. A. eds. Cell biology of breast cancer. New York: Academic Press; 1981: 425–450.
Medina, D.; DeOme, K. B.; Young, L. Tumor producing capabilities of hyperplastic alveolar nodules in virgin and hormone-stimulated BALB/cfC3H and C3Hf mice. J. Natl. Cancer Inst. 44: 167–174; 1970.
Faulkin, L. J. Hyperplastic lesions of mouse mammary glands after treatment with 3-methylcholanthrene. J. Natl. Cancer Inst. 36: 289–298; 1966.
Casto, B. C.; Pieczynski, W. J.; DiPaolo, J. A. Enhancement of adenovirus transformation by pretreatment of hamster cells with carcinogenic polycyclic hydrocarbons. Cancer Res. 33: 819–824; 1973.
Coggin, J. H. Enhanced virus transformation of hamster embryo cells in vitro. J. Virol. 3: 458–462; 1969.
Fisher, P. B.; Weinstein, I. B.; Eisenberg D.; Ginsberg, H. S. Interactions between adenovirus, a tumor promoter, and chemical carcinogens, in transformation of rat embryo cell cultures. Proc. Natl. Acad. Sci. USA 75: 2311–2314; 1978.
Fisher, P. B.; Weinstein, I. B. Chemical viral interactions and multiple aspects of cell transformation. Montesano, R.; Bartsch, H.; Tomatis, L. eds. Molecular and cellular aspects of carcinogen screening tests. Lyons, France: Intl. Agency for Research on Cancer; 1980: 113–131.
Freeman, A. E.; Weisburger, E. K.; Weisburger, J. H.; Wolford, R. G.; Maryak, J. M.; Huebner, R. J. Transformation of cell cultures as an indication of the carcinogenic potential of chemicals. J. Natl. Cancer Inst. 51: 799–808; 1973.
Rhim, J. S.; Vass, W.; Cho, H. Y.; Huebner, R. J. Malignant transformation induced by 7,12-dimethylbenz(a)anthracene in rat embryo cells infected with Rauscher leukemia virus. Intl. J. Cancer 7: 65–74; 1971.
Rhim, J. S.; Park, D. K.; Weisburger, E. K.; Weisburger, J. H. Evaluation of anin vitro assay system for carcinogens based on prior infection of rodent cells with nontransforming RNA tumor virus. J. Natl. Cancer Inst. 52: 1167–1173; 1974.
Price, P. J.; Bellew, T. M.; King, M. P.; Freeman, A. E.; Gilden, R. V.; Huebner, R. J. Prevention of viral-chemical co-carcinogenesis in vitro by type-specific anti-viral antibody. Proc. Natl. Acad. Sci. USA 73: 152–155; 1976.
Heidelberger, C. Chemical carcinogenesis. Ann. Rev. Biochem. 44: 79–121; 1975.
Weinstein, I. B.; Yamaguchi, N.; Gebert, R. Use of epithelial cell cultures for studies on the mechanism of transformation by chemical carcinogens. In Vitro 11: 130–141; 1975.
Igel, H. J.; Huebner, R. J.; Turner, H. C.; Kotin, P.; Falk, H. L. Mouse leukemia virus activation by chemical carcinogens. Science 166: 1624–1626; 1969.
Whitmire, C. E.; Salemo, R. A.; Rabstein, L. S.; Huebner, R. J.; Turner, H. C. RNA tumor virus antigen expression in chemically induced tumors. Virus-genome-specific common antigen detected by complement fixation in mouse tumors induced by 3-methylcholanthrene. J. Natl. Cancer Inst. 47: 1255–1263; 1971.
Rhim, J. S.; Dah, F. G.; Cho, H. Y.; Elder, E.; Vernon, M. L. Activation of a type-C RNA virus from tumors induced by rat kidney cells transformed by a chemical carcinogen. J. Natl. Cancer Inst. 50: 255–261; 1973.
Rapp, U. R.; Nowinski, R. C.; Reznikoff, C.; Heidelberger, C. Endogenous oncornaviruses in chemically induced transformation. 1. Transformation independent of virus production. Virology 65: 392–409; 1975.
Medina, D.; Butel, J. S.; Socher, S. H.; Miller, F. L. Mammary tumorigenesis in 7,12-dimethylbenzanthracene-treated C57BL × DBA/2f F1, mice. Cancer Res. 40: 368–373; 1980.
Vaidya, A. B.; Lasfargues, E. Y.; Sheffield, J. B.; Couthino, W. G. Murine mammary tumor virus (MuMTV) infection of an epithelial cell line established from C57BL/6 mouse mammary glands. Virology 90: 12–22; 1978.
Howard, D. K.; Schlom, J. Isolation of host-range variants of mouse mammary tumor viruses that efficiently infect cells in vitro. Proc. Natl. Acad. Sci. USA 75: 5718–5722; 1978.
Drohan, W.; Kettman, R.; Colcher, D.; Schlom, J. Isolation of the mouse mammary tumor virus sequences not transmitted as germinal provirus in the C3H and RIII mouse strains. J. Virol. 21: 986–995; 1977.
Lasfargues, E. Y.; Lasfargues, J. E.; Dion, A. S.; Greene, A. E.; Moore, D. H. Experimental infection of a cat kidney cell line with the mouse mammary tumor virus. Cancer Res. 36: 67–72; 1976.
Teramoto, Y. A.; Kufe, D.; Schlom, J. Multiple antigenic determinants on the major surface glycoprotein of murine mammary tumor viruses. Proc. Nat. Acad. Sci. USA 74: 3564–3568; 1977.
Teramoto, Y. A.; Schlom, J. Radioimmunoassays demonstrating type-specific and group-specific antigenic reactivities for the major internal structural protein of murine mammary tumor viruses. Cancer Res. 38: 1990–1995; 1978.
Howard, D. K.; Colcher, D.; Teramoto, Y. A.; Young, J. M.; Schlom, J. Characterization of mouse mammary tumor viruses propagated in heterologous cells. Cancer Res. 37: 2696–2704; 1977.
Howard, D. K.; Schlom, J. Differential host ranges for in vitro infectivity of mouse mammary tumor viruses. J. Gen. Virol. 47: 439–448; 1980.
Steiner, M. R.; Altenburg, B.; Richards, C. S.; Dudley, J. P.; Medina, D.; Butel, J. S. Differential response of cultured mouse mammary cells of varying tumorigenicity to cytochalasin B. Cancer Res. 38: 2719–2721; 1978.
Medina, D.; Oborn, C. J.; Asch, B. B. Distinction between preneoplastic and neoplastic mammary cell populations in vitro by cytochalasin B-induced multinucleation. Cancer Res. 40: 329–333; 1980.
Gambino, S. R.; Fonseca, I. Comparison of serum calcium requirements obtained with the SMA12/60 and by atomic absorption spectrophotometry. Clinical Chem. 17: 1047–1049; 1971.
Weinstein, I. B.; Wigler, M.; Stadler, U. Analysis of the mechanism of chemical carcinogenesis in epithelial cell cultures. Montesano, R.; Bartsch, H.; Tomatis, L. eds. Screening tests in chemical carcinogenesis, Lyons, France: Intl. Agency for Research on Cancer; 1976: 355–381.
Fisher, P. B.; Weinstein, I. B. In vitro screening tests for potential carcinogens. Sontag, J. M. ed. Carcinogens in industry and the environment. New York: Marcel Dekker; 1981: 113–166.
Voyles, B. A.; McGrath, C. M. Markers to distinguish normal and neoplastic mammary epithelial cells in vitro: Comparison of saturation density, morphology and concanavalin A reactivity. Intl. J. Cancer 18: 498–509; 1976.
Boynton, A. L.; Whitfield, J. F. Different calcium requirements for proliferation of conditionally and unconditionally tumorigenic mouse cells. Proc. Natl. Acad. Sci. USA 73: 1651–1654; 1976.
Boynton, A. L.; Whitfield, J. F.; Isaacs, R. J.; Trembley, R. G. Different extracellular calcium requirements for proliferation of non-neoplastic, preneoplastic and neoplastic mouse cells. Cancer Res. 37: 2657–2661; 1977.
Fisher, P. B.; Weinstein, I. B. Effects of tumor promoters and extracellular calcium on the growth of normal, transformed and temperaturesensitive rat liver epithelial cells. Cancer Lett. 10: 7–17; 1980.
Fisher, P. B.; Weinstein, I. B. Enhancement of cell proliferation in low calcium medium by tumor promoters. Carcinogenesis 2: 89–95; 1981.
Swierenga, S. H. H.; Whitfield, J. F.; Karasaki, S. Loss of proliferative calcium dependence: Simple in vitro indicator of tumorigenicity. Proc. Natl. Acad. Sci. USA 75: 6069–6072; 1978.
Boynton, A. L.; Whitfield, J. F. Calcium requirements for the proliferation of cells infected with a temperature-sensitive mutants of Rous sarcoma virus. Cancer Res. 38: 1237–1240; 1978.
Foulds, L. Neoplastic development. New York: Academic Press; 1960.
Weinstein, I. B.; Yamasaki, H.; Wigler, M.; Lee, L. S.; Fisher, P. B.; Jeffrey, A.; Grumberger, D. Molecular and cellular events associated with the action of initiating carcinogens and tumor promoters. Griffin, A. C.; Shaw, C. R. eds. Carcinogens, identification and mechanisms of action. New York: Raven Press; 1979: 399–418.
Freeman, A. E.; Price, P. J.; Igel, H. J.; Young, J. C.; Maryak, J. M.; Huebner, R. J. Morphological transformation of rat embryo cells induced by diethylnitrosamine and murine leukemia viruses. J. Natl. Cancer Inst. 44: 65–78; 1970.
Price, P. J.; Freeman, A. E.; Lane, W. T.; Huebner, R. J. Morphological transformation of rat embryo cells by the combined action of 3-methylcholanthrene and Rauscher leukemia virus. Nature 230: 144–145; 1971.
Slaga, T. J.; Sivak, A.; Boutwell, R. K. eds. Mechanisms of tumor promotion and cocarcinogenesis. New York: Raven Press; 1978.
Barrett, J. E.; Ts'o, P. O. P. Evidence for the progressive nature of neoplastic transformation in vitro. Proc. Natl. Acad. Sci. USA 75: 3761–3765; 1978.
Fisher, P. B.; Dorsch-Hasler, K.; Weinstein, I. B.; Ginsberg, H. S. Tumor promoters enhance anchorage-independent growth of adenovirus transformed cells without altering the integration pattern of viral sequences. Nature 281: 591–594; 1979.
Barrett, J. C.; Crawford, B. D.; Grady, D. L.; Hester, L. D.; Jones, P. A.; Benedict, W. F.; Ts'o, P. O. P. Temporal acquisition of enhanced fibrinolytic activity by Syrian hamster embryo cells following treatment with benzo(a)pyrene. Cancer Res. 3815–3823; 1977.
Fisher, P. B.; Weinstein, I. B.; Goldstein, N. I.; Young, C. S. H.; Carter, T. H. Modulation of adenovirus transformation and replication by chemical carcinogens and phorbol ester tumor promoters. Rich, M. A.; Furmanski, P. eds. Biological carcinogenesis. New York: Marcel Dekker; 1982: 261–290.
Hale, A. H.; Kucera, L. S.; Daniel, L. W.; Waite, M. Parameters distinguishing herpes simplex virus type 2-transformed tumorigenic and nontumorigenic cells. Cancer Res. 41: 629–634; 1981.
Milo, G. E.; Olsen, R. G.; Weisbrode, S. E.; McCloskey, J. A. Feline sarcoma virus induced in vitro progression from premalignant to neoplastic transformation of human diploid cells. In Vitro 16: 813–822; 1980.
Author information
Authors and Affiliations
Additional information
Support for these studies was provided in part by the National Cancer Institute, Bethesda, Md., Contract N01-CP-01018.
Rights and permissions
About this article
Cite this article
Howard, D.K., Schlom, J. & Fisher, P.B. Chemical carcinogen-mouse mammary tumor virus interactions in cell transformation. In Vitro 19, 58–66 (1983). https://doi.org/10.1007/BF02617995
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02617995